10x Genomics Inc — Quarterly Financial Data (NASDAQ:TXG) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

10x Genomics Inc

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

Notícias

Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%

Canadá - Ações fecharam o pregão em alta e o Índice S&P/TSX avançou 0,61%

Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?

Priceline, Carvana, DoorDash and more set to report earnings Wednesday

10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript

Preço-alvo das ações da 10X Genomics elevado para US$ 22 pela Canaccord Genuity

10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity

Applied Materials and Rivian among market cap stock movers on Friday

Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics

10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates

10X Genomics enfrenta teste de resultados com estreia de nova estratégia de preços

10X Genomics faces earnings test as new pricing strategy debuts